Higuchi, Makoto https://orcid.org/0000-0002-3934-5810
Tagai, Kenji
Takahata, Keisuke
Endo, Hironobu https://orcid.org/0000-0003-3398-597X
Article History
Accepted: 15 July 2025
First Online: 11 August 2025
Competing interests
: M.H. holds patents on PBB3, florzolotau and related compounds (JP 5422782/EP 12 884 742.3/CA2894994/HK1208672) and α-synuclein ligands (JP7460176). M.H. is supported by research grants from the Japan Agency for Medical Research and Development (JP24zf0127012 and JP24wm0625001) and Japan Science and Technology Agency (JPMJMS2024). The other authors declare no competing interests.